Citations (30)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Vittavat Termglinchan, Wachiraporn Wanichnopparat, Kulachanya Suwanwongse, Chunhakarn Teeyapant, Kanticha Chatpermporn, Kanchana Leerunyakul, Khwanruthai Chuadpia, Onpailin Sirimaneethum, Parinya Wijitworawong, Wattanakitch Mutirangura, Chatchawit Aporntewan, Chanida Vinayanuwattikun & Apiwat Mutirangura. (2013) Candidate cancer-targeting agents identified by expression-profiling arrays. OncoTargets and Therapy 6, pages 447-458.
Read now
Read now
Articles from other publishers (29)
Yuanchun Zhao, Xingqi Chen, Jiajia Chen & Xin Qi. (2023) Decoding Connectivity Map-based drug repurposing for oncotherapy. Briefings in Bioinformatics 24:3.
Crossref
Crossref
Nithya Krishnamurthy, Alyssa A. Grimshaw, Sydney A. Axson, Sung Hee Choe & Jennifer E. Miller. (2022) Drug repurposing: a systematic review on root causes, barriers and facilitators. BMC Health Services Research 22:1.
Crossref
Crossref
Theodora Katsila, Styliani A. Chasapi, Jose Carlos Gomez Tamayo, Constantina Chalikiopoulou, Eleni Siapi, Giorgos Moros, Panagiotis Zoumpoulakis, Georgios A. Spyroulias & Dimitrios Kardamakis. (2021) Three-Dimensional Cell Metabolomics Deciphers the Anti-Angiogenic Properties of the Radioprotectant Amifostine. Cancers 13:12, pages 2877.
Crossref
Crossref
Derek B. Oien, Christopher L. Pathoulas, Upasana Ray, Prabhu Thirusangu, Eleftheria Kalogera & Viji Shridhar. (2021) Repurposing quinacrine for treatment-refractory cancer. Seminars in Cancer Biology 68, pages 21-30.
Crossref
Crossref
Arun Balasubramaniam, Prakoso Adi, Do Thi Tra My, Sunita Keshari, Raman Sankar, Chien-Lung Chen & Chun-Ming Huang. (2020) Repurposing INCI-registered compounds as skin prebiotics for probiotic Staphylococcus epidermidis against UV-B. Scientific Reports 10:1.
Crossref
Crossref
Justin Bauzon, Garam Lee & Jeffrey Cummings. (2020) Repurposed agents in the Alzheimer’s disease drug development pipeline. Alzheimer's Research & Therapy 12:1.
Crossref
Crossref
Michel Montalvo-Casimiro, Rodrigo González-Barrios, Marco Antonio Meraz-Rodriguez, Vasti Thamara Juárez-González, Cristian Arriaga-Canon & Luis A. Herrera. (2020) Epidrug Repurposing: Discovering New Faces of Old Acquaintances in Cancer Therapy. Frontiers in Oncology 10.
Crossref
Crossref
Akeem A. Ayankunle, Olayemi K. Wakeel, Oyetunji T. Kolawole, Adesola O. Oyekale, Olusola Ojurongbe & Oluwaseyi A. Adeyeba. (2020) Drug Repositioning: Antimalarial Activities of GABA Analogs in Mice Infected with Plasmodium berghei. Central Nervous System Agents in Medicinal Chemistry 20:2, pages 110-121.
Crossref
Crossref
Ritesh Thakare, Manjulika Shukla, Grace Kaul, Arunava Dasgupta & Sidharth Chopra. (2019) Repurposing disulfiram for treatment of Staphylococcus aureus infections. International Journal of Antimicrobial Agents 53:6, pages 709-715.
Crossref
Crossref
Kyriaki Savva, Margarita Zachariou, Anastasis Oulas, George Minadakis, Kleitos Sokratous, Nikolas Dietis & George M. Spyrou. 2019. In Silico Drug Design. In Silico Drug Design
85
118
.
Tao Wang, Hai-Cheng Yi, Zhu-Hong You, Li-Ping Li, Yan-Bin Wang, Lun Hu & Leon Wong. 2019. Intelligent Computing Theories and Application. Intelligent Computing Theories and Application
344
353
.
Ladislav Peska, Krisztian Buza & Júlia Koller. (2017) Drug-target interaction prediction: A Bayesian ranking approach. Computer Methods and Programs in Biomedicine 152, pages 15-21.
Crossref
Crossref
Ritesh Thakare, Alok Kumar Singh, Swetarka Das, N. Vasudevan, Gorakhnath R. Jachak, D. Srinivasa Reddy, Arunava Dasgupta & Sidharth Chopra. (2017) Repurposing Ivacaftor for treatment of Staphylococcus aureus infections. International Journal of Antimicrobial Agents 50:3, pages 389-392.
Crossref
Crossref
D. Cavalla, E. Oerton & A. Bender. 2017. Comprehensive Medicinal Chemistry III. Comprehensive Medicinal Chemistry III
11
47
.
Remya Ramesh, Rahul D. Shingare, Vinod Kumar, Amitesh Anand, Swetha B, Sridhar Veeraraghavan, Srikant Viswanadha, Ramesh Ummanni, Rajesh Gokhale & D. Srinivasa Reddy. (2016) Repurposing of a drug scaffold: Identification of novel sila analogues of rimonabant as potent antitubercular agents. European Journal of Medicinal Chemistry 122, pages 723-730.
Crossref
Crossref
Holly Matthews, Maryam Usman-Idris, Farid Khan, Martin Read & Niroshini Nirmalan. (2013) Drug repositioning as a route to anti-malarial drug discovery: preliminary investigation of the in vitro anti-malarial efficacy of emetine dihydrochloride hydrate. Malaria Journal 12:1.
Crossref
Crossref
Francesco Iorio, Timothy Rittman, Hong Ge, Michael Menden & Julio Saez-Rodriguez. (2013) Transcriptional data: a new gateway to drug repositioning?. Drug Discovery Today 18:7-8, pages 350-357.
Crossref
Crossref
Michael S. Saporito, Christopher A. Lipinski & Andrew G. Reaume. 2012. Drug Repositioning. Drug Repositioning
253
290
.
John Arrowsmith & Richard Harrison. 2012. Drug Repositioning. Drug Repositioning
7
32
.
Kim Henriksen, Claus Christiansen & Morten Asser Karsdal. (2011) Serological biochemical markers of surrogate efficacy and safety as a novel approach to drug repositioning. Drug Discovery Today 16:21-22, pages 967-975.
Crossref
Crossref
Heng Luo, Jian Chen, Leming Shi, Mike Mikailov, Huang Zhu, Kejian Wang, Lin He & Lun Yang. (2011) DRAR-CPI: a server for identifying drug repositioning potential and adverse drug reactions via the chemical–protein interactome. Nucleic Acids Research 39:suppl_2, pages W492-W498.
Crossref
Crossref
S. J. Swamidass. (2011) Mining small-molecule screens to repurpose drugs. Briefings in Bioinformatics 12:4, pages 327-335.
Crossref
Crossref
V. J. Haupt & M. Schroeder. (2011) Old friends in new guise: repositioning of known drugs with structural bioinformatics. Briefings in Bioinformatics 12:4, pages 312-326.
Crossref
Crossref
Irene Seunghyun Hong, Heather J Ipema, Michael P Gabay & Amy E Lodolce. (2011) Medication Repurposing: New Uses for Old Drugs. Journal of Pharmacy Technology 27:3, pages 132-140.
Crossref
Crossref
Hirotaka Inoue & Shu Yamada. (2010) Failure mode and effects analysis in pharmaceutical research. International Journal of Quality and Service Sciences 2:3, pages 369-382.
Crossref
Crossref
Dmitry Filimonov & Vladimir Poroikov. 2008. Chemoinformatics Approaches to Virtual Screening. Chemoinformatics Approaches to Virtual Screening
182
216
.
Doreen Alberts. (2008) The ever-changing role of information professionals in pharmaceutical R&D. World Patent Information 30:3, pages 233-237.
Crossref
Crossref
David Borsook, David Bleakman, Richard Hargreaves, Jaymin Upadhyay, Karl F. Schmidt & Lino Becerra. (2008) A ‘BOLD’ experiment in defining the utility of fMRI in drug development. NeuroImage 42:2, pages 461-466.
Crossref
Crossref
Ulrich Nielsch, Stefan Schäfer, Hanno Wild & Andreas Busch. (2007) One target–multiple indications: a call for an integrated common mechanisms strategy. Drug Discovery Today 12:23-24, pages 1025-1031.
Crossref
Crossref